The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Diurnal Group Names Director Sam Williams Interim Chair

Thu, 05th Mar 2020 17:21

(Alliance News) - Diurnal Group PLC on Thursday said Non-Executive Director Sam William will assume the role of interim chair, effective from June 30.

Diurnal's current Non-Executive Chair Peter Allen will step down at the end of June, after a five-year stint.

Williams is the board representative of IP Group PLC, which holds a significant stake in Diurnal. He has over 20 years of experience in the biotechnology industry, both as a top-ranked equity analyst in the city and as an investor and chief executive, the pharmaceutical company said.

He has been on the board of Diurnal since 2015 and held the role of interim chairman prior to the appointment of Allen. He will temporarily replace Allen until a permanent successor is found.

"I would like to thank Peter for his considerable contribution to the company during the past five years. His extensive experience and wise counsel have been invaluable. He leaves Diurnal well-positioned to achieve its vision of becoming a world-leading specialty endocrinology company. We wish him the very best for the future," said Chief Executive Martin Whitaker.

Diurnal shares closed 2.8% lower at 32.45 pence each on Thursday in London.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2021 19:51

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
13 Sep 2021 20:23

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

Read more
7 Sep 2021 16:25

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 19:34

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

Read more
28 Jul 2021 18:07

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

Read more
12 Jul 2021 10:10

Diurnal agrees special protocol with FDA for Chronocort study

(Sharecast News) - Specialty pharmaceutical company Diurnal announced on Monday that the US Food and Drug Administration (FDA) has agreed a special protocol assessment (SPA) for 'Chronocort', or modified-release hydrocortisone, for the design, endpoints and statistical analysis approach of a pivotal study of the product, for the treatment for congenital adrenal hyperplasia (CAH).

Read more
2 Jul 2021 10:02

Diurnal gets UK approval for 'Efmody' treatment

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Friday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for 'Efmody', or hydrocortisone modified-release hard capsules, as treatment for adult and adolescent patients with the rare congenital adrenal hyperplasia (CAH) condition.

Read more
2 Jul 2021 10:01

Diurnal gets UK approval for Efmody drug following EU authorisation

Diurnal gets UK approval for Efmody drug following EU authorisation

Read more
29 Jun 2021 17:10

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

Read more
1 Jun 2021 20:24

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

Read more
28 May 2021 19:41

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Read more
12 May 2021 15:30

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

Read more
23 Apr 2021 12:56

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

Read more
23 Apr 2021 10:31

Diurnal granted European patent for Alkindi

(Sharecast News) - Hormonal disease-focussed speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.